General Electric Company (NYSE:GE) has filed an IPO to spin off its consumer credit segment. The company has been trying to reduce its reliance of GE Capital for quite some time to focus majorly on manufacturing segment. GE Capital is has been major earner for the group bring almost half the group revenues. The segment ran into the trouble during recession as it was highly dependent on consumer loans and risky commercial loans. Even GE Capital accounts to over 30% of group’s revenue; segment reported revenue of $44.1 Billion in year 2013 while revenue for year 2012 was $45.3 Billion and $48.3 Billion for 2011. The company has also renamed the business which handles the credit cards for stores like Wal-Mart Stores, Inc.(NYSE:WMT) to “Synchrony Financial” in a filing with Securities and Exchange Commission, SEC. General Electric Company (NYSE:GE) shares after opening at $25.58 moved to $25.71 on last trade day and at the end of the day closed at $25.70. Company price to sales ratio in past twelve months was calculated as 1.78 and price to cash ratio as 2.93. General Electric Company (NYSE:GE) showed a positive weekly performance of 0.19%.
AT&T Inc. (NYSE:T) has been hitting some very low price points in the first few months of 2014, following the hard-fought competition on the pricing of products in the crowded mobile marketing space. The result of the price drop was the drop in the yield of the stock as well. AT&T Inc. (NYSE:T) shares advanced 0.75% in last trading session and ended the day on $34.72. T return on equity ratio is recorded as 20.80% and its return on assets is 6.70%. AT&T Inc. (NYSE:T) yearly performance is 0.40%.
Pfizer Inc. (NYSE:PFE) made public the results of oral treatment Psoriasis Trial (OPT) compare (A3921080), a Phase 3 study of Xeljanz (tofacitinib). It is first of kind of oral Janus kinase (JAK) inhibitor treatment and it safety and efficacy are investigated so after successful trail it can be given to adults. This will be used for the treatment of chronic plaque psoriasis which can be normal to alarming level in adults. It was one of the largest clinical trials for the Psoriasis which was expanded over 36 countries and included 3600 patients. Pfizer Inc. (NYSE:PFE) shares moved up 1.05% in last trading session and was closed at $31.82, while trading in range of $31.59-$31.99. Pfizer Inc. (NYSE:PFE) year to date performance is 4.74%.
Verizon Communications Inc. (NYSE:VZ) have invested around $50 million in fiber optics and IP (Internet Protocol) networks in Delaware. The main beneficiary of this investment would be consumers, corporate and government organization. It sucks while watching TV or using internet or phone the quality is not up to mark even after paying the substantial amount. The whole entertainment experience turns into nightmare when the speed is low.Verizon Communications Inc. (NYSE:VZ) weekly performance is 1.11%. On last trading day company shares ended up $47.22. Verizon Communications Inc. (NYSE:VZ) distance from 50-day simple moving average is 0.20%. Analysts mean target price for the company is $53.88.
Leave a Reply